Predictive Value of the Hepatic Immune Predictive Index for Patients with Primary Liver Cancer Treated with Immune Checkpoint Inhibitors.
Sign Up to like & getrecommendations! Published in 2022 at "Digestive diseases"
DOI: 10.1159/000527574
Abstract: BACKGROUND Immune checkpoint inhibitors (ICIs) have improved survival outcomes and resulted in long-term responses in primary liver cancer in some patients. However, its efficacy is limited by the risk of tumor recurrence, resulting in rapid… read more here.
Keywords: liver cancer; hepatic immune; patients primary; immune predictive ... See more keywords